EUVIMEDEUVIMED entdecken
Crossref

Simultaneous activation of Kras–Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway

Mio Namikawa iD, Akihisa Fukuda, Kenta Mizukoshi, Kosuke Iwane, Munenori Kawai, Go Yamakawa, Mayuki Omatsu, Makoto Sono, Tomonori Masuda, Osamu Araki, Munemasa Nagao, Takaaki Yoshikawa iD und 10 weitere

The Journal of Pathology · 2023

DOI: 10.1002/path.6139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Mio Namikawa und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Cholangiocarcinoma, Carcinoma in Situ, Bile Duct Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Mitsubishi Foundation, Moonshot Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biliary tract cancer (BTC) has poor prognosis. The Notch receptor is aberrantly expressed in extrahepatic cholangiocarcinoma (eCCA). However, the role of Notch signaling in the initiation and progression of eCCA and gallbladder (GB) cancer remains unknown. Therefore, we investigated the functional role of Notch signaling during tumorigenesis of the extrahepatic bile duct (EHBD) and GB. Activation of Notch signaling and oncogenic Kras resulted in the development of biliary intraepithelial neoplasia (BilINs) in the EHBD and GB, which were premalignant lesions that progressed to adenocarcinoma in mice. The expression of genes involved in the mTORC1 pathway was increased in biliary spheroids from Hnf1b‐CreERT2 ; Kras LSL‐G12D ; Rosa26 LSL‐NotchIC mice and inhibition of the mTORC1 pathway suppressed spheroid growth. Additionally, simultaneous activation of the PI3K–AKT and Notch pathways in EHBD and GB induced biliary cancer development in mice. Consistent with this, we observed a significant correlation between activated NOTCH1 and phosphorylated Ribosomal Protein S6 (p‐S6) expression in human eCCA. Furthermore, inhibition of the mTORC1 pathway suppressed the growth of Notch‐activated human biliary cancer cells in vitro and in vivo . Mechanistically, the Kras/Notch–Myc axis activated mTORC1 through TSC2 phosphorylation in mutant biliary spheroids. These data indicate that inhibition of the mTORC1 pathway could be an effective treatment strategy for Notch‐activated human eCCA. © 2023 The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsCholangiocarcinomaCarcinoma in SituBile Duct NeoplasmsHumansMiceAnimalsProto-Oncogene Proteins c-aktMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesBile Ducts, Intrahepatic

Stichwörter der Autor:innen

BilINKrasMycNotchbiliary cancermTORC1

Substanzen

Proto-Oncogene Proteins c-aktMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kyoto-Katsura Hospital, Kyoto, Japan.
  • Tenri Hospital, Nara, Japan.
  • Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan.
  • Department of Drug Discovery Medicine, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Division of Hepatobiliary Pancreatic Surgery and Transplantation, Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

ORCID-Profile: Mio Namikawa, Takaaki Yoshikawa, Yuki Nakanishi

Förderung

  • Japan Agency for Medical Research and Development
  • Mitsubishi Foundation
  • Moonshot Research and Development Program
  • Princess Takamatsu Cancer Research Fund
  • Shimizu Foundation for Immunology and Neuroscience
  • Takeda Foundation
  • Naito Foundation

Zitieren

APA

Namikawa, M., Fukuda, A., Mizukoshi, K., Iwane, K., Kawai, M., Yamakawa, G., Omatsu, M., Sono, M., Masuda, T., Araki, O., Nagao, M., Yoshikawa, T., Ogawa, S., Hiramatsu, Y., Muta, Y., Tsuda, M., Maruno, T., Nakanishi, Y., Tsuruyama, T., …, & Seno, H. (2023). Simultaneous activation of Kras–Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway. The Journal of Pathology. https://doi.org/10.1002/path.6139

Vancouver

Namikawa M, Fukuda A, Mizukoshi K, Iwane K, Kawai M, Yamakawa G, et al. Simultaneous activation of Kras–Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway. The Journal of Pathology. 2023. doi:10.1002/path.6139

BibTeX
@article{Namikawa2023,
  author = {Namikawa, Mio and Fukuda, Akihisa and Mizukoshi, Kenta and Iwane, Kosuke and Kawai, Munenori and Yamakawa, Go and Omatsu, Mayuki and Sono, Makoto and Masuda, Tomonori and Araki, Osamu and Nagao, Munemasa and Yoshikawa, Takaaki and Ogawa, Satoshi and Hiramatsu, Yukiko and Muta, Yu and Tsuda, Motoyuki and Maruno, Takahisa and Nakanishi, Yuki and Tsuruyama, Tatsuaki and Taura, Kojiro and Hatano, Etsuro and Seno, Hiroshi},
  title = {Simultaneous activation of Kras–Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6139}
}
Kostenlos starten →